Frequent vascular access thrombosis in a patient with end stage kidney disease on hemodialysis.

David Kearney, Amanda Leonberg-Yoo, Raphael Cohen

Journal: Seminars in dialysis 2023;36(6):425-429

PMID: 37641427

Full Text on Ovid Technologies, Inc. View on PubMed

Abstract

Vascular access thrombosis (VAT) is common among patients receiving hemodialysis and leads to missed dialysis treatments, hospitalizations, catheter placement, and graft/fistula abandonment. This article reviews the association between hypercoagulability and VAT and the high prevalence of hypercoagulable states in end-stage kidney disease (ESKD). This article reviews the role of antithrombotic and anticoagulant medications in preventing VAT. The article concludes by reviewing the unique challenges of using vitamin K antagonists in patients with ESKD.

Address: Health Sciences North, Sudbury, Ontario, Canada.; University of Pennsylvania, Philadelphia, Pennsylvania, USA.

DOI: 10.1111/sdi.13172

Link outs

Free resources

Medical:

https://medlineplus.gov/kidneyfailure.html

Subscription / membership required

Full Text Sources:

MeSH Terms: Humans, Renal Dialysis, Kidney Failure, Chronic, Thrombosis, Anticoagulants, Arteriovenous Shunt, Surgical